We are live on ! Find out more
LPCN icon

Lipocine
LPCN

22 hedge funds and large institutions have $1.51M invested in Lipocine in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more funds holding

Funds holding: 18 → 22 (+4)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

0.11% less ownership

Funds ownership: 9.88% → 9.77% (-0.11%)

9% less capital invested

Capital invested by funds: $1.67M → $1.51M (-$158K)

Holders
22
Holders Change
+4
Holders Change %
+22.22%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Citadel Advisors
Citadel Advisors
Florida
+$43.3K
2
Renaissance Technologies
Renaissance Technologies
New York
+$3.95K
3
UBS Group
UBS Group
Switzerland
+$3.92K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.25K
5
TRCT
Tower Research Capital (TRC)
New York
+$1.51K

Top Sellers

1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$35.6K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$9.14K
3
Bank of America
Bank of America
North Carolina
-$7.71K
4
Osaic Holdings
Osaic Holdings
Arizona
-$58
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$635K -$9.14K -3,009 -1%
BlackRock
2
BlackRock
New York
$254K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$175K – – –
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$134K +$2.25K +742 +2%
Renaissance Technologies
5
Renaissance Technologies
New York
$103K +$3.95K +1,300 +4%
State Street
6
State Street
Massachusetts
$53.3K – – –
Citadel Advisors
7
Citadel Advisors
Florida
$40.7K +$43.3K +14,247 New
Northern Trust
8
Northern Trust
Illinois
$37.5K – – –
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$34.7K -$35.6K -11,722 -49%
Barclays
10
Barclays
United Kingdom
$26.8K – – –
Osaic Holdings
11
Osaic Holdings
Arizona
$6.46K -$58 -19 -0.8%
UBS Group
12
UBS Group
Switzerland
$5.03K +$3.92K +1,291 +272%
TRCT
13
Tower Research Capital (TRC)
New York
$3.33K +$1.51K +497 +74%
Morgan Stanley
14
Morgan Stanley
New York
$1.64K – – –
CSC
15
Caldwell Sutter Capital
California
$1.34K – – –
Group One Trading
16
Group One Trading
Illinois
$463 – – –
SS
17
SBI Securities
Japan
$191 – – –
Fidelity Investments
18
Fidelity Investments
Massachusetts
$169 +$179 +59 New
T
19
Tidemark
California
$168 – – –
Bank of America
20
Bank of America
North Carolina
$139 -$7.71K -2,538 -98%
Citigroup
21
Citigroup
New York
$9 +$9 +3 New
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
– +$3 +1 New

LPCN Hedge Fund Activity: Q3 2025 in Review

22 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Lipocine (LPCN) for Q3 2025, worth a combined $1.51M — down 9.4% from $1.67M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new LPCN positions and 0 closed out — a net gain of 4 holders — while 4 added to existing stakes and 4 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $43.3K. The largest seller was Dimensional Fund Advisors, cutting an estimated $35.6K.

  • 22 institutional investors held Lipocine (LPCN) as of Q3 2025, up from 18 in Q2 2025.
  • Funds reported $1.51M of Lipocine stock for Q3 2025, down 9.4% quarter-over-quarter.
  • 4 funds opened new Lipocine positions in Q3 2025 and 0 closed out, a net change of +4 holders.
  • The largest Lipocine buyer in Q3 2025 was Citadel Advisors, an estimated $43.3K added.
  • The largest Lipocine seller in Q3 2025 was Dimensional Fund Advisors, an estimated $35.6K sold.

Based on aggregated 13F filings for Q3 2025.